Invention Grant
- Patent Title: Sustained release formulation for oral administration of HMG-CoA reductase inhibitor and method for the preparation thereof
- Patent Title (中): 口服HMG-CoA还原酶抑制剂的缓释制剂及其制备方法
-
Application No.: US10599729Application Date: 2005-04-08
-
Publication No.: US08475840B2Publication Date: 2013-07-02
- Inventor: Jong Soo Woo , Hong-Gi Yi , Moon-Hyuk Chi , Jae-Kuk Ryu , Si-Young Jung , Yong-Il Kim
- Applicant: Jong Soo Woo , Hong-Gi Yi , Moon-Hyuk Chi , Jae-Kuk Ryu , Si-Young Jung , Yong-Il Kim
- Applicant Address: KR Hwaseong-si
- Assignee: Hanmi Science Co., Ltd
- Current Assignee: Hanmi Science Co., Ltd
- Current Assignee Address: KR Hwaseong-si
- Agency: Sughrue Mion, PLLC
- Priority: KR10-2004-0024734 20040410
- International Application: PCT/KR2005/001021 WO 20050408
- International Announcement: WO2005/097194 WO 20051020
- Main IPC: A61K47/00
- IPC: A61K47/00

Abstract:
The sustained release formulation for oral administration of an HMG-CoA reductase inhibitor of the present invention can be easily and economically prepared and is capable of maintaining a constant drug level in blood by slowly releasing the HMG-CoA reductase inhibitor at a uniform rate for 24 hrs. Accordingly, the sustained release formulation of the present invention can be effectively used for lowering blood cholesterol and triglyceride levels.
Public/Granted literature
Information query